Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

Baseline visual acuity strongly predicts visual acuity gain in patients with diabetic macular edema following anti-vascular endothelial growth factor treatment across trials

Pravin U Dugel,1,2 Jost Hillenkamp,3 Sobha Sivaprasad,4,5 Jessica Vögeler,6 Marie-Catherine Mousseau,7 Andreas Wenzel,8 Philippe Margaron,8 Ron Hashmonay,8 Pascale Massin9 1Retinal Consultants of Arizona LTD, Retinal Research Institute LLC, Phoenix, AZ, 2USC Eye Institute, Keck School of M...

Full description

Bibliographic Details
Main Authors: Dugel PU, Hillenkamp J, Sivaprasad S, Vögeler J, Mousseau MC, Wenzel A, Margaron P, Hashmonay R, Massin P
Format: Article
Language:English
Published: Dove Medical Press 2016-06-01
Series:Clinical Ophthalmology
Subjects:
aflibercept
anti-vascular endothelial growth factor
best corrected visual acuity
cross-trial comparison
diabetic macular edema
ranibizumab.
Online Access:https://www.dovepress.com/baseline-visual-acuity-strongly-predicts-visual-acuity-gain-in-patient-peer-reviewed-article-OPTH

Internet

https://www.dovepress.com/baseline-visual-acuity-strongly-predicts-visual-acuity-gain-in-patient-peer-reviewed-article-OPTH

Similar Items